NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 19 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,866 | +12.4% | 22,258,000 | +12.7% | 0.03% | +21.7% |
| Q2 2023 | $18,560 | +21.7% | 19,758,000 | +21.5% | 0.02% | +15.0% |
| Q1 2023 | $15,252 | +1698.6% | 16,258,000 | – | 0.02% | +1900.0% |
| Q4 2022 | $848 | -99.9% | 0 | – | 0.00% | 0.0% |
| Q3 2022 | $874,000 | +4.0% | 0 | – | 0.00% | 0.0% |
| Q2 2022 | $840,000 | -93.5% | 0 | -100.0% | 0.00% | -93.3% |
| Q1 2022 | $12,937,000 | +28.0% | 15,000,000 | +76.5% | 0.02% | +36.4% |
| Q4 2021 | $10,110,000 | -9.0% | 8,500,000 | +13.3% | 0.01% | -15.4% |
| Q3 2021 | $11,104,000 | – | 7,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,750,000 | $13,592,000 | 1.09% |
| Context Capital Management, LLC | 13,000 | $11,214,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 19,422,000 | $16,659,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,386,000 | $15,685,000 | 0.15% |
| Aequim Alternative Investments LP | 3,500,000 | $3,019,000 | 0.08% |
| LINDEN ADVISORS LP | 12,066,000 | $10,358,000 | 0.06% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 23,500,000 | $20,269,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $12,937,000 | 0.02% |
| D. E. Shaw & Co., Inc. | 16,900,000 | $14,517,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 10,323,000 | $8,800,358,000 | 0.01% |